During the COVID-19 (coronavirus) pandemic, the testing and sample analysis remain safe and do not represent any risk for the fetus. For the latest news regarding the NIPT test and the locations of the testing – if it currently isn't available at your preferred clinic – get in touch using the contact form on our website. We will gladly assist you with information or help you find the nearest clinic where you can perform the test.

The NIPT by GenePlanet test

Leading non-invasive prenatal test (NIPT) in the world. By November 2018, more than 5,000,000 samples were analyzed.

The NIPT test presentation

NIPT (Non-Invasive Prenatal Test) by GenePlanet is a safe and simple non-invasive prenatal test, which offers screening for certain genetic conditions after week 10 of pregnancy.

Using the latest genetic sequencing technology, NIPT by GenePlanet has over >99% sensitivity for the three most common trisomy conditions present at birth, which are Down Syndrome, Edwards Syndrome and Patau Syndrome.

More information


Non-invasive and without any risk of abortion.


After 10th week of pregnancy using 10 ml of mother's blood.


Sensitivity in trisomy detection, such as Down syndrome, is higher than 99%.


Over 5,000,000 tests have been carried out worldwide with only 0.05%* false positive results (* only for T21).

GenePlanet d.o.o., Cesta na Poljane 24, 1000 Ljubljana, Slovenia | +386 59 22 66 09 | nipt@geneplanet.com

During the COVID-19 the testing and sample analyses remain safe and do not represent any risk for the fetus.

Contact us, and we will gladly help you find the nearest open clinic.

This field is required.
This field is required.
This field is required.